The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

Researchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...

A credit-card-sized chip may soon outsmart cancer.A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device that could reshape how blood cancer treatments are ...

Multiple myeloma, a treatable but incurable blood cancer, is rising sharply in India, especially among those over 60. Dr.

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome Sanger Institute, the University of Cambridge, ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Read Ino’s inspiring cancer journey and discover how cutting-edge treatments and pediatric clinical trials are providing hope ...

Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...